Quality & complianceOfficial
FDA classes Victory Medical Center Pharmacy tirzepatide/L-carnitine recall as Class II over processing controls
🇺🇸 FDA enforcement report · Wed 11 Nov 2026
The recall of a compounded tirzepatide/L-carnitine multi-dose vial, cited for lack of processing controls, is ongoing and covers distribution in Colorado, Florida and Texas.
The US Food and Drug Administration has published a Class II drug recall in its enforcement report for a compounded injectable from Victory Medical Center Pharmacy. The product is listed as TIRZEPATIDE/L-CARNITINE (MDV) 25/50MG/ML, in a 1ML presentation.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Official source: FDA enforcement report ↗
Article written by VigiEye from the official source (FDA enforcement report). AI-assisted; check the source before acting.
More Quality & compliance
All →
BfArM publishes urgent field safety notice for Bentley InnoMed's BeFlow Iliac Covered Stent System
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM lists Siemens field safety notice for Dimension Urine Barbiturate Screen assay
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM publishes Medtronic MiniMed urgent field safety notice for MiniMed Go app
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM posts Merit Medical field safety notice for Philips BridgeT Balloon Prep Kit
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM posts Urgent Field Safety Notice for Biomet UK's Avantage Cup Gripper
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM publishes InterSystems field safety notice for TrakCare France software
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026